Januvia vs. Ozempic

See how Januvia and Ozempic compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Januvia is a once-daily pill for blood sugar control, while Ozempic is a once-weekly injection that also carries FDA approvals for heart and kidney protection.

  • Ozempic's most common side effects are gastrointestinal, like nausea and vomiting, while Januvia's most common issues are respiratory infections and swelling.

  • Januvia typically costs less per month than Ozempic, but only Ozempic is proven to lower cardiovascular and kidney disease risk in type 2 diabetes.

Januvia vs. Ozempic Drug Summary

Januvia

Januvia (sitagliptin) is a DPP-4 inhibitor used to control blood sugar in adults with type 2 diabetes, taken as a once-daily oral tablet alongside diet and exercise. It works by helping the body release more insulin after meals and lowering excess sugar production by the liver.

Ozempic

Ozempic (semaglutide) is a GLP-1 receptor agonist for blood sugar control in type 2 diabetes, given as a once-weekly subcutaneous injection alongside diet and exercise. It is also FDA-approved to reduce cardiovascular risk in patients with heart disease and to slow chronic kidney disease progression.

Januvia vs. Ozempic Side Effects

Januvia

Most common
nasopharyngitis (up to 11.0%)
peripheral edema (up to 8.3%)
headache (up to 5.5%)
diarrhea (up to 3.0%)

Ozempic

Most common
nausea (up to 20.3%)
vomiting (up to 9.2%)
diarrhea (up to 8.8%)
abdominal pain (up to 7.3%)

Januvia vs. Ozempic Dosage

Januvia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 2 increases As tolerated

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 2 mg once weekly If needed
Dose changes 3 increases Every 4 weeks

Januvia vs. Ozempic Indications

Januvia

Januvia is approved to improve blood sugar control in adults with type 2 diabetes when combined with diet and exercise. It is not approved for type 1 diabetes or diabetic ketoacidosis, and it does not carry any cardiovascular or kidney indication.

  • Blood sugar control in type 2 diabetes

  • Used alongside diet and exercise

  • Not approved for type 1 diabetes

  • Not approved for diabetic ketoacidosis

Ozempic

Ozempic is approved to improve blood sugar control in adults with type 2 diabetes and also carries approvals to reduce cardiovascular risk in heart disease and slow chronic kidney disease progression. It is not approved for type 1 diabetes or for chronic weight management, though it is sometimes used off-label for weight loss.

  • Blood sugar control in type 2 diabetes

  • Reduces cardiovascular risk in heart disease

  • Slows chronic kidney disease progression

  • Not approved for type 1 diabetes

Januvia vs. Ozempic Pros and Cons

Januvia

Januvia is an oral DPP-4 inhibitor that fits into a simple daily pill routine and carries no boxed warning. It has a weight-neutral profile and a lower list price than Ozempic, though it lacks proven cardiovascular or kidney benefits.

Pros

  • Oral pill, no needles required

  • No boxed warning on the label

  • Weight-neutral, unlikely to cause weight gain

  • Roughly $330 to $730 per month before insurance, well below Ozempic's list price

Cons

  • No FDA-approved cardiovascular or kidney benefit

  • Requires dose adjustment for kidney function

  • Can cause severe joint pain in rare cases

  • Less weight loss effect than GLP-1 drugs

Ozempic

Ozempic is a once-weekly injection with FDA-approved benefits beyond blood sugar control, including reduced cardiovascular risk and slower kidney disease progression. It typically costs more than Januvia and carries a boxed warning for thyroid C-cell tumors seen in animal studies.

Pros

  • FDA-approved to reduce cardiovascular risk in heart disease

  • FDA-approved to slow chronic kidney disease progression

  • Often leads to meaningful weight loss

  • Only one injection needed per week

Cons

  • Boxed warning for thyroid C-cell tumor risk

  • Higher rates of nausea and other GI side effects

  • Requires self-injection instead of a pill

  • Roughly $935 to $1,043 per month before insurance, more than Januvia

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.